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Abstract
Colorectal cancer (CRC) is believed to arise from mutant stem cells in colonic crypts that undergo a well-characterized
progression involving benign adenoma, the precursor to invasive carcinoma. Although a number of (epi)genetic events
have been identified as drivers of this process, little is known about the dynamics involved in the stage-wise progression
from the first appearance of an adenoma to its ultimate conversion to malignant cancer. By the time adenomas become
endoscopically detectable (i.e., are in the range of 1–2 mm in diameter), adenomas are already comprised of hundreds of
thousands of cells and may have been in existence for several years if not decades. Thus, a large fraction of adenomas may
actually remain undetected during endoscopic screening and, at least in principle, could give rise to cancer before they are
detected. It is therefore of importance to establish what fraction of adenomas is detectable, both as a function of when the
colon is screened for neoplasia and as a function of the achievable detection limit. To this end, we have derived
mathematical expressions for the detectable adenoma number and size distributions based on a recently developed
stochastic model of CRC. Our results and illustrations using these expressions suggest (1) that screening efficacy is critically
dependent on the detection threshold and implicit knowledge of the relevant stem cell fraction in adenomas, (2) that a
large fraction of non-extinct adenomas remains likely undetected assuming plausible detection thresholds and cell division
rates, and (3), under a realistic description of adenoma initiation, growth and progression to CRC, the empirical prevalence
of adenomas is likely inflated with lesions that are not on the pathway to cancer.
Citation: Dewanji A, Jeon J, Meza R, Luebeck EG (2011) Number and Size Distribution of Colorectal Adenomas under the Multistage Clonal Expansion Model of
Cancer. PLoS Comput Biol 7(10): e1002213. doi:10.1371/journal.pcbi.1002213
Editor: Marek Kimmel, Rice University, United States of America
Received March 7, 2011; Accepted August 14, 2011; Published October 13, 2011
Copyright:  2011 Dewanji et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institutes of Health Grant RO1 CA107028-05A1. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: gluebeck@fhcrc.org
Introduction
Adenomatous polyps (or adenomas) in the large intestine are
considered benign precursors of colorectal cancer (CRC) and both
clinical and molecular evidence suggest that they may sojourn for
many years before turning into cancer [1,2]. For this reason,
adenomas are considered a primary intervention target if detected
and removed before they become malignant. However, questions
remain regarding the significance of their histopathology, mole-
cular signatures, as well as their number and sizes in average risk
individuals. Since endoscopic screening for neoplastic lesions is
generally limited by macroscopic detection thresholds (of the order
of a few mm in caliper size), a large fraction of adenomas may
actually be missed, especially if the bulk of adenomas is too small
for detection. Potentially, such ‘‘occult’’ adenomas could give rise
to cancer before they are detected by endoscopy. Here we use a
biologically-based model of colorectal carcinogenesis, which has
previously been fitted to the age-specific incidence of CRC, to
compute the number and size distributions of adenomas. Of
particular interest is the fraction of detectable adenomas, as
functions of age, detection threshold and the underlying cell
kinetics in the adenomas.
The underlying multistage clonal expansion (MSCE) model for
CRC upon which our results are based explicitly considers the
initiation, promotion and malignant conversion of adenomas
[3–8]. According to this model, adenomas arise from normal
colonic stem cells that suffer at least two rare rate-limiting events.
We interpret these events as the biallelic inactivation of a tumor
suppressor gene, in particular the APC tumor suppressor gene,
which is the gene responsible for familial adenomatous polyposis
(FAP), and which is frequently mutated in colorectal neoplasia [9].
The inactivation of APC is understood to occur in colonic crypts
(the fundamental proliferative unit in the colon) whose stem cells
have previously acquired a mutation at one of the two APC alleles.
Because the process of adenoma formation may involve additional
genes (such as KRAS), we extend the model framework to
accommodate additional rate-limiting mutations for the initiation
of an adenoma and generalize the mathematical derivation of their
number and size distribution accordingly. However, there is both
clinical and experimental evidence that the number of requisite
rate-limiting events or mutations for adenoma initiation is small.
Once a stem cell is initiated in this model, it is free to proliferate.
The basic version of our CRC model assumes that adenoma
initiation occurs when the remaining wild-type copy of the
APC tumor suppressor gene is deleted or mutated in a stem
cell of a (pre-initiated) APC+/2 colonic crypt. In a more realistic
model, which is supported by recent experimental findings in the
murine system [10], we also model the transient amplification of
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adding a stage to the initiation process [10–12].
The theoretical results derived here are complemented by
model predictions for the adenoma size distributions and their
(age-specific) prevalence based on parameter estimates obtained
previously from fitting cancer incidence data. Since not all
biological model parameters can be directly estimated from
incidence data alone (non-identifiability issue), we explore the
sensitivity of our findings by varying unknown parameters, such as
the cell division rate of initiated stem cells, within their plausible
ranges. In spite of the model uncertainties and the lack of precise
clinical data on adenoma number and sizes, a biologically based
approach that is broadly consistent with the pathogenesis of CRC
makes it possible to explore more rationally the impact of risk
factors and interventions on adenoma development and cancer
progression.
Model
The Multistage Clonal Expansion (MSCE) Model
First we briefly review the MSCE model for CRC and then
introduce the notation for the relevant stochastic processes
involved in the formation of adenomas. We have previously
derived expressions for the number and size distribution of non-
extinct pre-malignant clones in the context of the two-stage clonal
expansion (TSCE) model [13]. This model assumes that the clones
develop from a (deterministic) source of progenitor cells via a non-
homogeneous Poisson process. An important extension of this
work was put forward by Dewanji et al. [14] for the size
distribution of a random sum of Poisson-generated (pre-malignant)
clones, which corresponds to a generalized Luria-Delbru ¨ck (GLD)
distribution for mutant colonies. A hallmark of this distribution is a
long tail reflecting large fluctuations of the total (mutant)
population size. A further extension derived expressions for the
number and size distributions of pre-malignant clones condition-
ing on observations from individuals who have not previously been
diagnosed with CRC [6].
Adenoma development. For colorectal adenomas, the
MSCE model assumes that adenomas arise within colonic crypts
maintained by immortal stem cells that have accumulated K(§1)
requisite (epi)genetic pre-initiation events. In this model, adenomas
are allowed to be multi-focal since the initiation process, starting
from the time when the Kth pre-initiation event has occurred in a
stem cell, is a point process representing the continuous generation
of initiated cells from the K-stage cell, the progeny of which is free
to undergo clonal expansion. In this picture, pre-initiated stem
cells are blocked from clonal expansion; however, they are allowed
to divide asymmetrically to generate daughter cells that will
(ultimately) undergo terminal differentiation (see Figure 1). This is
described in more detail below. To give an example, for a 3-step
initiation model (K~2), adenomas arise from crypts whose stem
cell population sustains two consecutive hits (e.g., the inactivation
of both alleles of the APC gene). In this case initiating events occur
when the crypt stem cells suffer a third event.
Pre-initiation events. There are two distinct biological ways
for pre-initiation events to occur at the cellular level. A pre-
initiation event may occur in a stage k(k~1,   ,K) stem cell via
an asymmetric stem cell division in which a mutation occurs in one
of the two daughter stem cells. In other words, a stem cell in the
kth pre-initiation stage may divide asymmetrically to yield two
daughter stem cells, one in stage k and the other in stage (kz1)
which acquires a new mutation (Figure 1A). This process is
mathematically modeled as a Poisson process with intensity rate
mk(:). In this case, both daughters are retained in the stem cell
compartment. The other possibility is represented by another kind
of asymmetric stem cell division which causes one daughter stem
cell to acquire a mutation leading to a transition of this cell to stage
(kz1), while the other daughter is committed to differentiation
(Figure 1. B). For historical reasons, we refer to this event as an
Armitage-Doll (AD) type transition [15].
For both cases we assume that a stage k(ƒK) stem cell is not
yet initiated and therefore lacks the potential for clonal expansion
via symmetric cell divisions. However, once a stem cell enters stage
(Kz1), it is considered initiated and free to undergo clonal
expansion. Furthermore, all stem cells in the pre-initiation stages
are assumed immortal.
Multi-focal nature of an adenoma. In the context of the
MSCE model for CRC, an adenoma consists of the collection of
all initiated (stage Kz1) cells that derive from a single stage K
progenitor cell. This definition, while not unique, is consistent with
the assumption that the stage K progenitor may be subject to
transient amplification, which is represented by frequent Poisson
‘emissions’ of initiated (stage Kz1) cells that are free to undergo
independent clonal expansions resulting in the formation of
multiple sub-clones (Figure 1C).
We call this ensemble of sub-clones an adenoma or adenomatous
polyp. Since information on adenoma number and sizes is typically
obtained via screening of individuals who have not previously been
diagnosed with CRC, we will also derive the results of the model
conditioning on no prior clinical detection of CRC. For this
purpose, we assume that the last rate-limiting event (with rate
mKz1(:)) in the MSCE model, which is usually associated with the
malignant conversion of an initiated cell, represents detection of a
clinical cancer as in Jeon et al. [6].
Basic notation. Suppose there are K(§1) pre-initiation
stages. We refer to the kth pre-initiation event as a Pk-mutation
and the cells, which have gone through this Pk-mutation, as Pk-
cells (k~1,   ,K). For completeness, we refer to the normal stem
cells as P0-cells. The generation of Pk-cells from one Pk{1-cell can
be modeled through a non-homogeneous PP with rate mk{1(:) per
cell. Alternatively, it can be modeled as a direct transition of a
Pk{1-cell into a Pk-cell, the AD-type transition referred to above,
with hazard rate mk{1(:) and density fk{1(:) for the waiting time of
Author Summary
The adenomatous polyp (or adenoma) is considered the com-
mon precursor lesion for colorectal cancer (CRC). Although
the natural history of adenomas is well-characterized in
terms of their histopathology and (epi)genomic changes,
little is known about their dynamics in the stage-wise
progression from the first appearance of an adenoma to its
conversion to malignant cancer. By the time adenomas
become endoscopically detectable (i.e., are in the range
of 1–2 mm in diameter), adenomas are already comprised
of hundreds of thousands of cells. A large fraction of
adenomas may therefore remain undetected during screen-
ingand, inspiteoftheirsmall(subthreshold)size, couldgive
rise to cancer prior to being detected. It is therefore of
importance to establish what fraction of adenomas is
detectable, both as a function of the age at screening for
colorectal neoplasia and the size (threshold) above which
adenomas can be detected reliably. Here we derive
mathematical expressions for the distribution of adenoma
number and sizes based on a recently developed stochastic
model for CRC, which has previously been calibrated and
validated against age-specific CRC incidence data.
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transition, it is assumed that the functions mk{1(:) and fk{1(:)
depend only on the time since the Pk{1-mutation occurred. If
mk{1(:) is a constant, then fk{1(:) is the density of an exponen-
tial distribution. Once a PK-cell is formed (by means of a PK-
mutation), it generates initiated cells (i.e., PKz1-cells) according to
a non-homogeneous PP with rate mK(:) and the initiated cells grow
according to a linear birth and death process with rates a(:) and
b(:), respectively. Note, the initiation of PKz1-cells and their
clonal expansion recapitulates the two-stage clonal expansion
(TSCE) model for which explicit solutions for the number and size
distributions have been derived [13]. Figure 1.C illustrates the
MSCE model for carcinogenesis. The pre-initiation events can be
either PP-type or AD-type transitions. However, the first step in
the MSCE model represents the successive (random) generation of
P1 mutant stem cells over time and throughout the normal tissue,
which is assumed to be very large in size - about 108 normal stem
cells in colon and rectum combined. Hence, without loss of
generality, the MSCE model assumes that the arrivals of the first
mutations are of the PP-type.
Size and detection of an adenoma. Suppose we observe,
for an individual at a particular time t, the number of detectable
adenomas, N(t), and their sizes (in terms of the number of initiated
or PKz1-cells in each adenoma), fYi(t),i~1,   ,N(t)g.W e
assume that an adenoma is detectable with probability one if its
size is greater than a fixed threshold y0. In the following sections,
we derive the joint distribution of fN(t), Yi(t),i~1,   ,N(t) ðÞ g for
different values of K and different assumptions regarding the type
of pre-initiation process (i.e., PP or AD). For K~2, we essentially
consider the model recommended by Luebeck & Moolgavkar [12]
for CRC and used by Jeon et al. [6] for evaluating screening
strategies for adenomas in colon and rectum. The latter study
provided an efficient approach to simulate the natural history of
CRC by recognizing that the size of the adenomas, given the
arrival time of a PK-cell, follows a GLD distribution as derived by
Dewanji et al. [14].
Let sK be the time of a particular PK-mutation, that is, the
arrival time for a progenitor cell (a PK{cell) for an adenoma.
Then this progenitor cell will generate initiated cells (PKz1{cells)
by a Poisson process, and each initiated cell forms a sub-clone of
PKz1{cells via a clonal expansion. Note, Y(sK,t) is the (random)
sum of all sub-clones of initiated cells (PKz1{cells) that were
generated from the PK progenitor stem cell which was born at
time sKvt.
In particular, when the initiation rate mK(:), the cell division
rate a(:), and the cell death rate b(:) are constants, the GLD
distribution reduces to a Negative Binomial distribution (Eq. (3.34)
in [6]), given by
pn(sK,t):P½Y(sK,t)~njY(sK,sK)~0 
~
mK=azn{1
mK=a{1
 !
(1{af)
mK=a(af)
n,n§0,
ð1Þ
where Y(sK,t) denotes the size of the adenoma at time t, given the
time of PK-mutation sK, and
f~
e(a{b)(t{sK){1
ae(a{b)(t{sK){b
:
Under these assumptions, the sub-clones that lead to this (multi-
focal) distribution arise from initiated PKz1-cells that expand
clonally by following a linear birth-death process. For this reason,
the results derived here are readily applied to the situation when
the sub-clones are also identified clinically. Conditioning this
distribution on adenomas that occur in cancer-free individuals,
i.e., individuals who have not had a prior occurrence of CRC, we
Figure 1. Multistage clonal expansion (MSCE) model. SC: stem cell, D: differentiated cell.
doi:10.1371/journal.pcbi.1002213.g001
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p 
n(sK,t):P½Y(sK,t)~njZ(sK,t)~0,Y(sK,sK)~0 
~
mK=azn{1
mK=a{1
 !
(1{afc)
mK=a(afc)
n,n§0,
ð2Þ
where
fc~
e{p(t{sK){e{q(t{sK)
(qza)e{p(t{sK){(pza)e{q(t{sK) , ð3Þ
p~
1
2
({azbzmKz1{
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
(azbzmKz1)
2{4ab
q
), ð4Þ
q~
1
2
({azbzmKz1z
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
(azbzmKz1)
2{4ab
q
), ð5Þ
and Z(sK,t) is the indicator variable for clinical detection of cancer
at time t with PK-cells born at time sK.
Number and Size Distribution for K~1
For K~1 we have only one pre-initiation event, defined by a
P1-mutation, and P2-cells are the initiated cells. As mentioned in
the previous section, the P1-mutation follows a PP formulation.
Let Y(s1,t) denote the size of the adenoma at time t with the first
pre-initiation (P1-mutation) time s1. The distribution of Y(s1,t) is
given by the GLD distribution previously derived by Dewanji et al.
[14], for the process originating at time s1 and involving the
initiation rate mK(:)~m1(:) and the birth and death rates of the
initiated cells given by a(:) and b(:), respectively.
As mentioned before, we assume that the generation of P1-cells
follows a non-homogeneous PP with rate m0(:)X(:), where X(:)
gives the deterministic growth curve for the normal stem cells in
the tissue. Let M(t) be the number of first pre-initiations (P1-
mutations) by time t and let s1j, j~1,   ,M(t) be the occurrence
times of these P1-mutations. Also, write N(s1j,t)~I(Y(s1j,t)wy0),
where I(:) is the indicator function. That is, N(s1j,t)~1, if the
corresponding adenoma is detectable at time t, and 0 otherwise.
Then, the number of detectable adenoma N(t) can be written as a
filtered Poisson process
N(t)~
X M(t)
j~1
N(s1j,t):
The probability generating function (PGF) of N(t) can be written
as
y
(1)(u;t)~exp
ðt
0
m0(s1)X(s1) y(u;s1,t){1 fg ds1
  
, ð6Þ
where y(u;s1,t) is the PGF of the binary variate N(s1,t) with
success probability
p
(1)
1 (s1,t)~P½N(s1,t)~1 ~P½Y(s1,t)wy0jY(s1,s1)~0 :
Note that p
(1)
1 (s1,t) is the probability that a P1-mutation taking
place at time s1 results in a detectable adenoma at time t. This
probability can be obtained from the distribution of Y(s1,t). For
constant parameters, this reduces to, using (1) with K~1,
p
(1)
1 (s1,t)~1{
Py0
n~0 pn(s1,t).
Adenoma prevalence. It follows that the number of P1-cells
which lead to detectable adenomas at time t follows a non-
homogeneous PP with rate m0(s1)X(s1)p
(1)
1 (s1,t),w i t hs1ƒt,a n d
N(t) has a Poisson distribution with mean
Ð t
0 m0(s1)X(s1)p
(1)
1 (s1,t)ds1.
Since the adenoma prevalence is defined as the probability of at least
one detectable adenoma at age t, it is given by
1{P½N(t)~0 ~1{exp {
ðt
0
m0(s1)X(s1)p
(1)
1 (s1,t)ds1
  
: ð7Þ
Detection probability and size distribution of ade-
nomas. The probability of detecting an adenoma of size
Y(t)wy0 at age t is given by
P½Y(t)wy0 ~
X ?
i~y0z1
ðt
0
m0(s1)X(s1)P½Y(s1,t)~ijY(s1,s1)~0 
Ð t
0 m0(s1)X(s1)ds1
ds1: ð8Þ
For constant parameters, this reduces to
1
t
ðt
0
p
(1)
1 (s1,t)ds1. Simi-
larly, the size distribution of a detectable adenoma at age t is given by
P½Y(t)~yjY(t)wy0 ~
Ð t
0m0(s1)X(s1)P½Y(s1,t)~yjY(s1,s1)~0 ds1
Ð t
0 m0(s1)X(s1)p
(1)
1 (s1,t)ds1
:ð9Þ
Likelihood for the number and size of detectable
adenomas. Using the properties described above, it is
straightforward to show that the joint probability (or likelihood
L1) of having n detectable adenomas with sizes yi,i~1,   ,n at
age t, i.e, fN(t)~n,(Yi(t)~yi,i~1,   ,n)g is
L1~P½N(t)~n 
| P
n
i~1
ðt
0
m0(s1)X(s1)p
(1)
1 (s1,t)
Ð t
0 m0(s1)X(s1)p
(1)
1 (s1,t)ds1
P½Y(s1,t)~yijY(s1,s1)~0 
p
(1)
1 (s1,t)
"#
ds1
()
!exp {
ðt
0
m0(s1)X(s1)p
(1)
1 (s1,t)ds1
  
P
n
i~1
ðt
0
m0(s1)X(s1)P½Y(s1,t)~yijY(s1,s1)~0 ds1
  
:
ð10Þ
Extension to observations in individuals with no prior
CRC. Here we derive analogous results for cancer-free individuals,
i.e., individuals who have not developed CRC by time t.T ot h i se n d ,
we require the conditional probability p
(1 )
1 (s1,t) that a P1-mutation
taking place at time s1, results in a detectable adenoma at time t prior
to developing CRC. Hence, we need to compute the conditional
probability p
(1 )
1 (s1,t)~P½Y(s1,t)wy0jZ(s1,t)~0,Y(s1,s1)~0 .F o r
constant parameters, using (2), p
(1 )
1 (s1,t) can be calculated as
1{
Py0
n~0 p 
n(s1,t).
Adenoma prevalence among individuals with no prior
CRC. As before, the number of detectable adenoma at time
t in a cancer-free individual, N (t), follows a Poisson distri-
bution with mean given by
Ð t
0 m0(s1)X(s1)S2(s1,t)p
(1 )
1 (s1,t)ds1,
where the two-stage survival function S2(s1,t) represents the
probability that a P1-cell born at time s1 does not lead to CRC by
time t. Thus, the adenoma prevalence conditioned on cancer-free
is given by
1{exp {
ðt
0
m0(s1)X(s1)S2(s1,t)p
(1 )
1 (s1,t)ds1
  
: ð11Þ
ð10Þ
ð8Þ
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been derived previously, i.e.
S2(s1,t)~
q{p
qe{p(t{s1){pe{q(t{s1)
   m1=a
,
where p and q are defined in (4) and (5) with K~1 (see [6,12] for
details).
Detection probability, size distribution, and likelihood
function for adenomas in individuals with no prior
CRC. Here we provide analogous expressions for the detection
probability (8) and size distribution (9), but properly conditioned
on no occurrence of prior CRC. The probability of detecting an
adenoma at age t with size ywy0, conditioned on no prior CRC,
can be written as
P½Y(t)wy0jZ(t)~0 
~
X ?
i~y0z1
ðt
0
m0(s1)X(s1)S2(s1,t)P½Y(s1,t)~ijZ(s1,t)~0,Y(s1,s1)~0 
Ð t
0 m0(s1)X(s1)S2(s1,t)ds1
ds1
~
Ð t
0 m0(s1)X(s1)S2(s1,t)p
(1 )
1 (s1,t)ds1 Ð t
0 m0(s1)X(s1)S2(s1,t)ds1
:
ð12Þ
Similarly, for the size distribution of detectable adenomas (i.e.,
their sizes exceeding the threshold y0) at age t, conditioned on no
prior CRC, we find
P½Y(t)~yjY(t)wy0,Z(t)~0 
~
Ð t
0 m0(s1)X(s1)S2(s1,t)P½Y(s1,t)~yjZ(s1,t)~0,Y(s1,s1)~0 ds1
Ð t
0 m0(s1)X(s1)S2(s1,t)p
(1 )
1 (s1,t)ds1
:
ð13Þ
Finally, following the derivation of (10), the joint distribution of
the number and sizes of detectable adenomas, in a cancer-free
individual, can be written as
L 
1!exp {
ðt
0
m0(s1)X(s1)S2(s1,t)p
(1 )
1 (s1,t)ds1
  
| P
n
i~1
ðt
0
m0(s1)X(s1)S2(s1,t)P½Y(s1,t)~yijZ(s1,t)~0,Y(s1,s1)~0 ds1
  
:
ð14Þ
Number and Size Distribution for K~2
Here the two pre-initiation events (P1- and P2-mutations)
precede initiation and growth of initiated P3-cells into sub-clones.
Let Y(s1,s2,t) denote the size of the adenoma at time t with the
corresponding P1- and P2-mutations taking place at times s1 and
s2, respectively. Note that the distribution of Y(s1,s2,t) is given by
the GLD distribution originating at time s2 and involving the
initiation rate mK(:)~m2(:) and the birth and death rates of the
initiated or P3-cells, given by a(:) and b(:), respectively. We derive
explicit expressions for the number and size distributions for the
case when both P1- and P2-mutations are of PP-type. The case
when the P2-mutations are of AD-type is described in the online
supplement (Text S1).
As before, the number of detectable adenomas at time t can be
written as
N(t)~
X M(t)
j~1
N(1)(s1j,t), ð15Þ
where N(1)(s1j,t) is the number of detectable adenomas that
emerged from a P1-cell born at time s1jƒt. Then, as in (6), the
PGF of N(t) can be expressed by
y
(2)(u;t)~exp
ðt
0
m0(s1)X(s1) y
(1)(u;s1,t){1
  
ds1
  
, ð16Þ
where y
(1)(u;s1,t) is the PGF of N(1)(s1,t). Using the Lemma and
eq. (10) of Dewanji et al. [14], we have further
P0(t)~P½N(t)~0 ~y
(2)(0;t)
~exp {
ð t
0
m0(s1)X(s1)1 {P½N(1)(s1,t)~0 
  
ds1
  
,
ð17Þ
and for n§1,
Pn(t)~P½N(t)~n ~
X n{1
i~0
n{i
n
Pi(t)q
(1)
n{i(t), ð18Þ
where, for l§1,q
(1)
l (t)~
Ð t
0 m0(s1)X(s1)P½N(1)(s1,t)~l ds1.
Again,
N(1)(s1,t)~
X
j
N(s1,s2j,t), ð19Þ
where this sum is over all the P2-mutations by time t that occurred
at times s2jƒt and which emerged from a P1-cell that was born at
time s1. Here, N(s1,s2,t)~1 if the adenoma originated from the
P1-cell born at time s1 and the P2-cell born at time s2 is detectable
at time t and 0 otherwise; that is, N(s1,s2,t)~I(Y(s1,s2,t)wy0).
Note that Y(s1,s2,t)~Y(s2,t), since Y(s1,s2,t) does not depend on
s1. Therefore, as in the previous section, N(1)(s1,t) is a filtered PP
with the PGF y
(1)(u;s1,t), similar to that in (6). Also, N(1)(s1,t) is a
non-homogeneous PP with rate m1(s2)p
(1)
2 (s2,t), for s1ƒs2ƒt, and
for fixed t, is a Poisson variate with mean
Ð t
s1 m1(s2)p
(1)
2 (s2,t)ds2,
where
p
(1)
2 (s2,t)~P½N(s1,s2,t)~1 ~P½Y(s2,t)wy0jY(s2,s2)~0 : ð20Þ
This probability can be obtained from the distribution of Y(s2,t)
given in (1).
Adenoma prevalence. p
(1)
2 (s2,t) has the same form as that of
p
(1)
1 (s1,t) but with K~2. Thus, using (17), the adenoma prevalence
is calculated by
1{exp {
ðt
0
m0(s1)X(s1)1 {exp {
ðt
s1
m1(s2)p
(1)
2 (s2,t)ds2
"# ()
ds1
"#
: ð21Þ
The distribution of N(t) can now be obtained by using (18), and
the expected number of detectable adenomas can be readily
obtained using (16), i.e.
E½N(t) ~
L
Lu
y
(2)(u;t)
       
u~1
~
ðt
0
m0(s1)X(s1)
ðt
s1
m1(s2)p
(1)
2 (s2,t)ds2ds1: ð22Þ
ð12Þ
ð14Þ
ð21Þ
ð22Þ
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nomas. The probability of detecting an adenoma of size
Y(t)wy0 at age t is given by
P½Y(t)wy0 
~
X ?
i~y0z1
ðt
0
m0(s1)X(s1)
Ð t
s1 m1(s2)P½Y(s2,t)~ijY(s2,s2)~0 ds2
Ð t
0 m0(s1)X(s1)
Ð t
s1 m1(s2)ds2ds1
ds1:
ð23Þ
For constant pre-initiation rates m0 and m1, and a constant
normal stem cell number X, this reduces to 2
Ð t
0 s2p
(1)
2 (s2,t)ds2=t2.
Similarly, the size distribution of a detectable adenoma at age t is
simply given by
P½Y(t)~yjY(t)wy0 
~
Ð t
0 m0(s1)X(s1)
Ð t
s1 m1(s2)P½Y(s2,t)~yjY(s2,s2)~0 ds2ds1
Ð t
0 m0(s1)X(s1)
Ð t
s1 m1(s2)p
(1)
2 (s2,t)ds2ds1
:
ð24Þ
Likelihood for the number and size of detectable
adenomas. Let Ms(t) be the number of ‘special’ P1-
mutations that lead to at least one detectable adenoma at time t.
Because of the filtered-Poisson-process nature of the generation of
the adenomas, the occurrence of such special P1-mutations follows
a PP with rate m0(s1)X(s1)p
(2)
1 (s1,t), for s1ƒt, where p
(2)
1 (s1,t) is
the probability that a P1-mutation that occurred at time s1 leads to
at least one detectable adenoma by time t. Using the distribution
of N(1)(s1,t), we have
p
(2)
1 (s1,t)~1{P½N(1)(s1,t)~0 
~1{exp {
ðt
s1
m1(s2)p
(1)
2 (s2,t)ds2
"#
:
ð25Þ
We now turn to the joint distribution of having n detect-
able adenomas with sizes yi,i~1,   ,n at age t, i.e,
fN(t)~n, Yi(t)~yi,i~1,   ,n ðÞ g , when nw0. First, let Ni(t)
denote the number of detectable adenomas arising out of the ith
‘special’ P1-mutation with sizes Yij(t),~1,   ,Ni(t). Clearly,
PMs(t)
i~1 Ni(t)~N(t). Then, given Ms(t)~mw0, the events
fNi(t),Yij(t),j~1,   ,Ni(t)g, for i~1,   ,m, are independent
and identically distributed with
P½Ni(t)~ni, Yij(t)~yij, j~1,   ,nijm ~
ðt
0
m0(s1)X(s1)p
(2)
1 (s1,t)ds1
   {1
|
ðt
0
m0(s1)X(s1)p
(2)
1 (s1,t)
e
{
Ð t
s1
m1(s2)p(1)
2 (s2,t)ds2 Ð t
s1 m1(s2)p
(1)
2 (s2,t)ds2
   ni
=ni!
p
(2)
1 (s1,t)
| P
ni
j~1
ðt
s1
m1(s2)p
(1)
2 (s2,t)
Ð t
s1 m1(s2)p
(1)
2 (s2,t)ds2
P½Y(s2,t)~yijjY(s2,s2)~0 
p
(1)
2 (s2,t)
ds2
8
<
:
9
=
;
ds1:
ð26Þ
Therefore, the joint probability of fMs(t)~mg and
fNi(t)~ni,Yij(t)~yij, j~1,   ,nig for i~1,   ,m, is given by
L(m,ni,yij,j~1,   ,ni,i~1,   ,m)
~ m! P
m
i~1
ni!
   {1
exp {
ðt
0
m0(s1)X(s1)p
(2)
1 (s1,t)ds1
  
| P
m
i~1
ðt
0
m0(s1)X(s1)e
{
Ð t
s1
m1(s2)p(1)
2 (s2,t)ds2
 
| P
ni
j~1
ðt
s1
m1(s2)P½Y(s2,t)~yijjY(s2,s2)~0 ds2
()
ds1
!
:
ð27Þ
In order to derive the joint distribution of
fN(t)~n, Yi(t)~yi,i~1,   ,n ðÞ g , using (27), let N~f1,   ,ng
denote the set of labels for the n clones. Then, summing over all
possible m and the possible partitions of N with m subsets, the
likelihood is given by
L2~
X n
m~1
X
(I1,   ,Im)
L(m,ni,yij,j[Ii,i~1,   ,m),
where I1,   ,Im are disjoint subsets of N with |m
i~1Ii~N, and
the second sum is over all such (I1,   ,Im) with ni~jIij, the
number of labels in Ii.I fn is not very large, this sum is not difficult
to work with.
Extension to observations in individuals with no prior
CRC. Analogous results can be obtained for observations in
individuals who have not developed clinical CRC by time t
by directly conditioning the Poisson rates and using conditional
size distributions for Y(s2,t). For example, the relevant joint
distribution of adenoma number and sizes (i.e., (27)) can be
obtained by the following substitutions:
p
(1)
2 (s2,t)?p
(1 )
2 (s2,t)~P½Y(s2,t)wy0jZ(s2,t)~0,Y(s2,s2)~0 ,
m0(s1)X(s1)?m0(s1)X(s1)S3(s1,t),
m1(s2)?m1(s2)S2(s2,t),
and P½Y(s2,t)~yijjY(s2,s2)~0  is replaced by
P½Y(s2,t)~yijjZ(s2,t)~0,Y(s2,s2)~0 :
Note, S3(s1,t) and S2(s2,t) represent the respective probabilities
that a P1-cell born at time s1 and a P2-cell born at time s2 do not
give rise to CRC by time t. In other words, they are the tumor
survival functions of a 3-stage and 2-stage carcinogenesis model,
respectively. For constant parameters, these survival functions are
as following (see [6,12] for the derivation):
S2(s2,t) ~
q{p
qe{p(t{s2){pe{q(t{s2)
   m2=a
,
S3(s1,t) ~exp {
Ð t{s1
0 m1 1{
q{p
qe{ps{pe{qs
   m2=a
ds
  
,
ð28Þ
ð26Þ
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details). Thus, the conditional expression for adenoma prevalence
is given by
1{exp {
ðt
0
m0(s1)X(s1)S3(s1,t)1 {exp {
ðt
s1
m1(s2)S2(s2,t)p
(1 )
2 (s2,t)ds2
"# ()
ds1
"#
: ð29Þ
The expected number of detectable adenomas conditioned
on no prior CRC can be obtained through analogous replace-
ments in (22).
Detection probability and size distribution for adenomas
in individuals with no prior CRC. As before for the case with
K~1, we also provide analogous expressions for the detection
probability (23) and size distribution (24), but properly conditioned
on no previous occurrence of CRC. The probability of detecting
an adenoma at age t with size ywy0, becomes
P½Y(t)wy0jZ(t)~0 
~
X ?
i~y0z1
ðt
0
m0(s1)X(s1)S3(s1,t)
Ð t
s1 m1(s2)S2(s2,t)P½Y(s2,t)~ijZ(s2,t)~0,Y(s2,s2)~0 ds2
Ðt
0 m0(s1)X(s1)S3(s1,t)
Ð t
s1 m1(s2)S2(s2,t)ds2ds1
ds1
~
Ðt
0 m0(s1)X(s1)S3(s1,t)
Ð t
s1 m1(s2)S2(s2,t)p
(1 )
2 (s2,t)ds2ds1
Ð t
0 m0(s1)X(s1)S3(s1,t)
Ð t
s1 m1(s2)S2(s2,t)ds2ds1
,
ð30Þ
and for the size distribution of detectable adenomas (i.e., their
sizes exceeding the threshold y0) at age t, conditioned on no prior
CRC, we have
P½Y(t)~yjZ(t)~0,Y(t)wy0 
~
Ð t
0 m0(s1)X(s1)S3(s1,t)
Ð t
s1 m1(s2)S2(s2,t)P½Y(s2,t)~yjZ(s2,t)~0,Y(s2,s2)~0 ds2ds1
Ð t
0 m0(s1)X(s1)S3(s1,t)
Ð t
s1 m1(s2)S2(s2,t)p
(1 )
2 (s2,t)ds2ds1
:
ð31Þ
Number and Size Distribution for General K
The notation introduced in the previous section is easily
generalized to Kw2. The random variable Y(s1,   ,sK,t) denotes
the size of the adenoma at time t with the corresponding
P1-,    ,PK-mutation times s1,   ,sK, respectively. The distribu-
tion of Y(s1,   ,sK,t) is, as before, given by the GLD distribution
with time origin at sK and with initiation rate mK(:). Initiated
PKz1-cells divide or die with rates a(:) and b(:), respec-
tively. Importantly, Y(s1,   ,sK,t) depends on sK alone (i.e.,
Y(s1,   ,sK,t)~Y(sK,t)), and the distribution is given by (1) for
constant parameters.
Various combinations of AD-type and PP-type generations for
the K pre-initiations are possible, but the formulation of the
likelihood becomes more complicated. The special cases when all
pre-initiations are of PP-type or AD-type are covered in the online
supplement (Text S1).
Results
The derived expressions allow us to readily predict both
observable and unobservable numbers of pre-malignant tumors
in a tissue. Such predictions are helpful in validating cancer
models using intermediate endpoints on precursor lesions, in
particular their number and sizes. Furthermore, being able to
predict the unobserved portion of precursor lesions is of cli-
nical relevance for early detection and cancer prevention. Here,
we illustrate the utility of the derived expressions using the
example of colonic adenomas. Specifically, we present the
predicted size distribution of adenomas and the age-specific
adenoma prevalence, i.e., the probability of finding at least one
observable adenoma in an individual as a function of age. Since
population-level screening is typically performed on asymptom-
atic individuals, we also condition on individuals having not
developed cancer in the tissue of interest at the time of
observation.
The predictions presented here are for K~2 as described
above. The underlying CRC model for cancer incidence is the 4-
stage model previously derived by Luebeck & Moolgavkar [12]
and updated by Meza et al. [7]. The alternative model (PP for P1-
and AD for P2-mutation for K~2 in the online supplement (Text
S1)) yields very similar results (not shown). Importantly, not all
biological parameters of the MSCE/CRC model are estimable
from incidence data alone. For example, for the 4-stage model
used here, only the parameters p,q, the product (slope parameter)
m0Xm1, and the ratio m2=a are identifiable. However, if the cell
division rate of initiated cells, a, is known, all parameters of the
model can be determined (assuming that the number of normal
tissue stem cells, X, is known and that m0~m1). For our
illustrations, we choose plausible values for the cell division rate
a, but keep the values of p,q,m0Xm1, and m2=a as estimated by
Meza et al. [7]. This affords explicit computation of the adenoma
number and size distribution without altering the fits of the model
to the observed CRC incidence.
Figure 2 (left panel) shows the predicted size distribution of non-
extinct adenoma without an imposed detection threshold (i.e.,
y0~0) for the model with K~2. With constant parameters, both
the unconditional and conditional (on no prior CRC development)
size distributions of detectable adenoma are given by expressions
(24) and (31), respectively.
For sizes sufficiently large, the unconditional adenoma size
distribution is roughly log-log-linear, while the conditional size
distribution shows departures from this behavior for sizes above
*100,000 cells, i.e., when the risk of an adenoma-to-carcinoma
transition increases more rapidly. This phenomenon is more
noticeable when the cell division rate a is lower. Figure 2 (right
panel) shows the probability of detecting an adenoma at age 70 as
a function of the detection threshold y0 for both unconditional
(solid) and conditional (dashed) adenoma size distributions. Higher
cell division rates (a) give rise to larger adenoma sizes and hence
lead to higher detection probabilities even though the net cell
proliferation rate (*{p) is approximately the same. For constant
parameters, the unconditional and conditional detection proba-
bilities are given by (23) and (30), respectively. This figure reveals
that even for relatively small (i.e., sensitive) thresholds of a few
thousand cells, many adenomas may go undetected. However, the
precise proportion of detectable adenomas depends on the cell
division rate a with higher values of a making detection more
likely.
Figure 3 shows the predicted age-specific adenoma prevalence
in asymptomatic individuals for both males and females and
for the models with K~1 and K~2, as described by Meza et al.
[7], including their dependence on the observation threshold y0.
The prevalence is defined as the probability of at least one
detectable adenoma at age t, and is given by (11) for K~1 and
(29) for K~2. In comparison with careful observations from
autopsy studies [16], the model under-estimates these empirical
data (represented by filled circles) unless one accepts a very small
number of initiated stem cells to be observable. There are several
explanations why the model-generated expected prevalence of
adenoma might be lower than the clinical data would indicate (see
the end of Discussion).
ð29Þ
ð30Þ
ð31Þ
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We have previously derived number and size distributions of
pre-malignant clones in the context of the two-stage clonal
expansion (TSCE) model of carcinogenesis [13,17] and more
recently established a formal connection of these results with
fluctuation analyses based on the Luria-Delbru ¨ck distribution [14].
The mathematical tools derived in these papers were subsequently
applied to the problem of screening for colorectal adenoma
allowing for interventions resulting from their complete or
incomplete removal [6]. These explorations, however, required
time consuming computer simulations. In contrast, here we derive
mathematical expressions that allow us to readily compute
adenoma number and size distributions without simulation. These
expressions can form the basis for computing the likelihood of
adenoma data from screening studies involving sigmoidoscopies,
colonoscopies and computed-tomographic colonographies, and
thus are of significantly practical importance. Moreover the
analytical form of the likelihood function allows for parameter
estimation and likelihood-based hypothesis testing. Analyses of
such data will be forthcoming and are the subject of a separate
paper.
Our previous analyses of CRC incidence data suggest that K,
the number of requisite pre-initiation mutations, is indeed small
Figure 2. Size distribution of a detectable adenoma and probability of detection of an adenoma. Left panel: predicted unconditional
(solid) and conditional (dashed) size distribution of a detectable adenoma at age 70 using the parameter estimates obtained by [7] for females in
SEER with K~2 and y0~0. The cell division rate of initiated cells, a, is assumed as either 9 or 90/year. Right panel: the probability of detection of an
adenoma at age 70 as a function of the detection threshold y0. Otherwise same as left panel.
doi:10.1371/journal.pcbi.1002213.g002
Figure3.Adenomaprevalence.Predictedadenomaprevalenceforbothmales(Leftpanel)andfemales(Rightpanel)asafunctionofageandvarious
observation thresholds y0 using the models with K~2 (solid lines) and K~1 (dashed lines). Empirical data from Clark et al. [16] in filled circles.
doi:10.1371/journal.pcbi.1002213.g003
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essence representing the biallelic inactivation of a tumor
suppressor gene (Knudson’s recessive oncogenesis) [7]. A model
with K~2 may describe both the inactivation of a tumor
suppressor gene as well as the activation of an oncogene [7,12].
Here, we also treat the case of general K, which can be viewed as a
model for clonal evolution due to the tree-structure where the
nodes represent immortal mutant stem cells that will give rise to
specific sub-clones which may or may not be identified as such. We
distinguish between two types of rate-limiting events, one that
generates (potentially multiple) mutations via asymmetric cell
division while preserving the progenitor stem cell from which the
mutations arose (PP-type), and one that leads to a transition of a
progenitor cell into one cell that acquires a new mutation (AD-
type). The MSCE model used here assumes that all events that
lead to initiated cells are PP-type. This is only a mild restriction
since for rare events the PP-type emission is equivalent to a AD-
type transition (see Figure 1). For frequent (high rate) events, the
AD-type transition looses its rate-limiting nature and can be
ignored, while the high rate (PP-type) process leads to the
accumulation of multiple clones and thus has the potential to
capture non-mutational events, such as the transient amplification
of proliferative cells from resident stem cells in the colonic crypts.
Once a stem cell is considered initiated, i.e., is of type PKz1,w e
assume that it undergoes a stochastic birth-death process. This
leads to the GLD distribution introduced in [14] for the adenoma
size Y(s1,   ,sK,t), which reduces to a Negative Binomial
distribution for constant parameters. Note, however, our formal-
ism is more general and can accommodate other growth models
that do not result in a GLD size distribution for the initiated cell
population emerging from a PK progenitor cell [17,18].
Finally, we wish to comment on the predictions of the model for
the age-specific adenoma prevalence (Figure 3). In comparison
with the empirical data, our predictions appear too low. However,
the discrepancy depends on what is assumed for the initiated stem
cell division rate a and the detection threshold y0. While the range
of plausible values for a is limited by how fast initiated stem cell
can cycle in the adenoma (unlikely more than 2–3 times a week), it
is not clear what fraction of cells in an adenoma is truly at risk for
malignant transformation [10]. Assuming that a 1 mm adenoma,
the caliper size detection limit cited by Clark et al. [16], contains
about 500,000 cells [19] and that only 1–10% of cells in an
adenoma are tumor stem cells [10,20], y0 may be as low as 5000
cells and therefore the discrepancy may be less dramatic.
Alternatively, one might include pre-initiated cells in the adenoma
size count. However, our assumption is that pre-initiated cells do
not expand clonally, although they may increase in number as a
result of multiple births of the same type of mutation from a single
stem cell over time (via Poisson process emissions). Thus, since
locus-specific mutations are rare (of the order of 10{6 to 10{7 per
year), the contribution of pre-initiated cells to the overall number
of cells in an adenoma is likely very small.
It is well-recognized that adenomas can be genetically diverse
and differ widely in their neoplastic potential. Indeed, adenomas
have been suggested to regress implying that there are adenomas
that are not on the pathway to cancer [21], although regression
may simply reflect the stochastic nature of tumor growth. A more
intriguing possibility of resolving the discrepancy is that adenomas
go through a growth-bottleneck (i.e., stagnancy) before they can
become cancerous. In this scenario, adenomas might sojourn in a
reservoir until an activating mutation or change in tumor
microenvironment releases them from arrest [22,23]. Although
incorporating this scenario into the MSCE model may be
challenging, the framework presented here is independent of the
particular dynamics of the initiated cells and the number of clonal
expansions assumed.
Supporting Information
Text S1 Supplementary methods and results. A tabular glossary
which summarizes our notation and succinctly defines the model
parameters and terminology in use.
(PDF)
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